Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 3
2013 2
2014 5
2015 2
2016 5
2017 7
2018 5
2019 6
2020 4
2021 9
2022 8
2023 9
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review.
Kołodrubiec J, Kozłowska M, Irga-Jaworska N, Sędek Ł, Pastorczak A, Trelińska J, Młynarski W. Kołodrubiec J, et al. Among authors: pastorczak a. Leuk Res. 2022 Oct;121:106925. doi: 10.1016/j.leukres.2022.106925. Epub 2022 Aug 2. Leuk Res. 2022. PMID: 35939887 Review.
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
van Bladel DAG, Stevens WBC, Kroeze LI, de Groen RAL, de Groot FA, van der Last-Kempkes JLM, Berendsen MR, Rijntjes J, Luijks JACW, Bonzheim I, van der Spek E, Plattel WJ, Pruijt JFM, de Jonge-Peeters SDPWM, Velders GA, Lensen C, van Bladel ER, Federmann B, Hoevenaars BM, Pastorczak A, van der Werff Ten Bosch J, Vermaat JSP, Nooijen PTGA, Hebeda KM, Fend F, Diepstra A, van Krieken JHJM, Groenen PJTA, van den Brand M, Scheijen B. van Bladel DAG, et al. Among authors: pastorczak a. Blood Adv. 2023 Oct 10;7(19):5911-5924. doi: 10.1182/bloodadvances.2023010412. Blood Adv. 2023. PMID: 37552109 Free PMC article.
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies.
Elitzur S, Shiloh R, Loeffen JLC, Pastorczak A, Takagi M, Bomken S, Baruchel A, Lehrnbecher T, Tasian SK, Abla O, Arad-Cohen N, Astigarraga I, Ben-Harosh M, Bodmer N, Brozou T, Ceppi F, Chugaeva L, Dalla Pozza L, Ducassou S, Escherich G, Farah R, Gibson A, Hasle H, Hoveyan J, Jacoby E, Jazbec J, Junk S, Kolenova A, Lazic J, Lo Nigro L, Mahlaoui N, Miller L, Papadakis V, Pecheux L, Pillon M, Sarouk I, Stary J, Stiakaki E, Strullu M, Tran TH, Ussowicz M, Verdu-Amoros J, Wakulinska A, Zawitkowska J, Stoppa-Lyonnet D, Taylor AM, Shiloh Y, Izraeli S, Minard-Colin V, Schmiegelow K, Nirel R, Attarbaschi A, Borkhardt A. Elitzur S, et al. Among authors: pastorczak a. Blood. 2024 Sep 12;144(11):1193-1205. doi: 10.1182/blood.2024024283. Blood. 2024. PMID: 38917355
Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey.
Bobeff K, Pastorczak A, Urbanska Z, Balwierz W, Juraszewska E, Wachowiak J, Derwich K, Samborska M, Kalwak K, Dachowska-Kalwak I, Laguna P, Malinowska I, Smalisz K, Gozdzik J, Oszer A, Urbanski B, Zdunek M, Szczepanski T, Mlynarski W, Janczar S. Bobeff K, et al. Among authors: pastorczak a. Children (Basel). 2023 Apr 19;10(4):745. doi: 10.3390/children10040745. Children (Basel). 2023. PMID: 37189994 Free PMC article.
Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia.
Fidyt K, Pastorczak A, Goral A, Szczygiel K, Fendler W, Muchowicz A, Bartlomiejczyk MA, Madzio J, Cyran J, Graczyk-Jarzynka A, Jansen E, Patkowska E, Lech-Maranda E, Pal D, Blair H, Burdzinska A, Pedzisz P, Glodkowska-Mrowka E, Demkow U, Gawle-Krawczyk K, Matysiak M, Winiarska M, Juszczynski P, Mlynarski W, Heidenreich O, Golab J, Firczuk M. Fidyt K, et al. Among authors: pastorczak a. Mol Oncol. 2019 May;13(5):1180-1195. doi: 10.1002/1878-0261.12476. Epub 2019 Apr 5. Mol Oncol. 2019. PMID: 30861284 Free PMC article.
CD19-CAR T-cell therapy with sorafenib in post-HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch-A case report and review of the literature.
Oszer A, Kołodrubiec J, Pawlik B, Marschollek P, Ćwilichowska N, Jakubowska J, Bukowska-Strakova K, Surman M, Trelińska J, Miarka-Walczyk K, Haze N, Liszka K, Mielcarek-Siedziuk M, Kałwak K, Poręba M, Pastorczak A, Janczar S, Młynarski W. Oszer A, et al. Among authors: pastorczak a. Br J Haematol. 2024 Sep;205(3):1215-1219. doi: 10.1111/bjh.19608. Epub 2024 Jun 26. Br J Haematol. 2024. PMID: 38924036 No abstract available.
Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.
Domka K, Dąbkowska A, Janowska M, Urbańska Z, Pastorczak A, Winiarska M, Fidyt K, Lachota M, Patkowska E, Sędek Ł, Perkowski B, Hunia J, Jakubowska J, Krzymieniewska B, Lech-Marańda E, Młynarski W, Szczepański T, Firczuk M. Domka K, et al. Among authors: pastorczak a. Haematologica. 2024 Nov 1;109(11):3520-3532. doi: 10.3324/haematol.2023.284853. Haematologica. 2024. PMID: 38841802 Free PMC article.
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia.
Pastorczak A, Domka K, Fidyt K, Poprzeczko M, Firczuk M. Pastorczak A, et al. Cancers (Basel). 2021 Mar 26;13(7):1536. doi: 10.3390/cancers13071536. Cancers (Basel). 2021. PMID: 33810515 Free PMC article. Review.
70 results